Table 1.
Author | Age (yr) | Sex | Time after TKA | Affected side | History of gout/pseudogout | Diagnosis | Associated infection | Surgical treatment? | Medical treatment | Final follow-up | Successful outcome?a |
---|---|---|---|---|---|---|---|---|---|---|---|
Williamson et al. [5] | 86 | F | 10 y | Left | N/a | Gout | No | Y | Colchicine, allopurinol | 1 y | Y |
Blyth et al. [6] | 58 | M | 4 y | Right | Y | Gout | Staphylococcus aureus | Y | Antibiotics | N/a | N |
52 | M | 3 d | Right | Y | Gout | No | N | NSAIDs, colchicine, allopurinol | 1 y | Y | |
Archibeck et al. [7] | 66 | M | 10 and 12 y | Bilateral | N | Gout | No | Y | Colchicine, allopurinol | 5 mo | Y |
88 | F | 9 y | Left | Y | Gout | No | Y | Colchicine | 4 mo | Y | |
Crawford et al. [8] | 59 | F | 3 mo | Left | N | Gout | No | N | NSAIDs, allopurinol | 1 y | Y |
Salin et al. [9] | 50s | F | 4 and 4 y | Bilateral | N | Gout | No | Y | Allopurinol, steroids | 1 mo | Y |
80s | F | 11 y | Left | Y | Gout | Escherichia coli | Y | Antibiotics, NSAIDs | N/a | Y | |
Berger et al. [10] | 39 | M | 4 y | Right | Y | Gout | No | Y | NSAIDs, colchicine | N/a | Y |
Fokter et al. [11] | 68 | M | 11 mo | Left | N/a | Gout | No | N | NSAIDs, allopurinol | 1 wk | Y |
Freehill et al. [12] | 77 | F | 10 y | Right | Y | Gout | Escherichia coli | Y | Antibiotics | 8 wk | Y |
Partridge et al. [15] | 66 | F | 8 y | Right | Y | Gout | No | Y | Antibiotics, steroids | 1 y | Y |
Chen et al. [14] | 43 | M | 7 y | Left | Y | Gout | No | N | Colchicine, allopurinol, steroids | 1 y | Y |
72 | M | 10 y | Right | Y | Gout | No | N | Steroids | 5 mo | Y | |
Yahia et al. [19] | 72 | F | 31 d | Left | N/a | Gout | No | N | Colchicine | N/a | N/a |
Zadaka et al. [13] | 58 | F | 7 y | Right | N | Gout | No | N | Steroids, allopurinol | 2 d | Y |
77 | M | 13 and 20 y | Bilateral | N | Gout/Pseudogout | No | N | Anitibiotics | "several days" | Y | |
Levi et al. [16] | 70 | F | 8 y | Bilateral | N/a | Pseudogout | No | Y | Antibiotics, steroids | 16 mo | Y |
Koyama et al. [17] | 64 | F | 13 d | Right | N | Pseudogout | No | N | NSAIDs | 1 y | Y |
81 | M | 2 wk | Left | N | Pseudogout | No | N | NSAIDs | 1 y | Y | |
Harato et al. [18] | 85 | M | 15 d | Right | Y | Pseudogout | No | N | NSAIDs | 1 y | Y |
Yahia et al. [19] | 79 | M | 7 d | Right | N/a | Pseudogout | No | N | Colchicine | N/a | N/a |
73 | F | 3 y | Right | N/a | Pseudogout | No | N | NSAIDs | N/a | N/a | |
67 | M | 9 y | Right | N/a | Pseudogout | No | N | Steroids, colchicine | N/a | N/a | |
77 | F | 15 d | Right | N/a | Pseudogout | Campylobacter fetus | N | Antibiotics | N/a | N/a | |
Holt et al. [20] | 72 | M | 2 y | Left | N | Pseudogout | No | Y | NSAIDs | 1 wk | Y |
Hirose et al. [21] | 59 | F | 7 d | Right | Y | Pseudogout | No | N | NSAIDs | 1 y | Y |
Sonsale et al. [22] | 69 | F | 10 y | Right | N | Pseudogout | No | N | NSAIDs | 8 y | Y |
NSAIDs, nonsteroidal anti-inflammatory drugs.
Successfwl outcome defined as no recurrence of presenting symptoms.